The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

iwMyeloma 2017 | Why one size should not fit all for multiple myeloma

Name: Why one size should not fit all for multiple myeloma
Uploaded: 2017-10-18T00:00:00.000Z
Duration: 56 s
Description: Within multiple myeloma (MM), there are biologically different diseases that are distinctly characterized. In this video, Gareth Morgan, MD, FRCP, FRCPath, PhD from the UAMS Myeloma Institute, Little Rock, AR, speaking from the Myeloma 2017 meeting in Edinburgh, UK, talks passionately about this hot topic. He highlights the need for risk-stratified treatment in MM.

Gareth Morgan • 18 Oct 2017

iwMyeloma 2017

Multiple Myeloma

Within multiple myeloma (MM), there are biologically different diseases that are distinctly characterized. In this video, Gareth Morgan, MD, FRCP, FRCPath, PhD from the UAMS Myeloma Institute, Little Rock, AR, speaking from the Myeloma 2017 meeting in Edinburgh, UK, talks passionately about this hot topic. He highlights the need for risk-stratified treatment in MM.